Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.03 (-2.27%)
As of: Oct 21, 2026 · 3:10 PM EDT

Nervgen Pharma (NGEN) Share-based Compensation (2025 - 2026)

Updated

Nervgen Pharma (NGEN) reported Share-based Compensation of $1.98 million for the quarter ended Jun 30, 2026, up 35.8% from $1.46 million a year earlier and up 184.9% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Share-based Compensation (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nervgen Pharma's Share-based Compensation came in at $5.15 million; for the year ended Dec 31, 2025, it was $3.86 million, down 12.5% from the prior year.

  • By year, Share-based Compensation came in at $4.41 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn 166.00 Mn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn -
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn -
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 249.00 Mn
10 Nervgen Pharma 108.86 Mn 7.74 Mn - 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.98 Mn
Mar 31, 2026 694,299.34
Jun 30, 2025 1.46 Mn
Mar 31, 2025 1.02 Mn
API Access

Nervgen Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NGEN&period=max&api_key=YOUR_API_KEY